Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database
Author(s) -
François Raffi,
Yazdan Yazdanpanah,
Francis Fagnani,
Caroline Laurendeau,
A Lafuma,
J. Gourmelen
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv083
Subject(s) - efavirenz , cart , emtricitabine , medicine , regimen , persistence (discontinuity) , cohort , pill , atazanavir , human immunodeficiency virus (hiv) , antiretroviral therapy , pharmacology , viral load , virology , geotechnical engineering , engineering , mechanical engineering
To compare adherence and persistence (continuous treatment with a prescribed medication) in HIV adult patients who received combination ART (cART) as a once-daily single-tablet regimen (STR) versus other administration schedules.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom